Johnson & Johnson  

(Public, NYSE:JNJ)   Watch this stock  
Find more results for JNJ
69.71
+0.49 (0.71%)
Real-time:   12:11PM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 69.36 - 69.75
52 week 59.08 - 69.75
Open 69.48
Vol / Avg. 3.75M/14.49M
Mkt cap 191.45B
P/E 22.18
Div/yield 0.61/3.50
EPS 3.14
Shares 2.75B
Beta 0.54
Inst. own 65%
Oct 16, 2012
Q3 2012 Johnson & Johnson Earnings Conference Call - 8:30AM EDT - Add to calendar
Jul 17, 2012
Q2 2012 Johnson & Johnson Earnings Conference Call
Jun 2, 2012
Johnson & Johnson at American Society of Clinical Oncology Annual Meeting - Pre Recorded Webcast
May 9, 2012
Johnson & Johnson at Deutsche Bank AG Health Care Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q3 (Jul '12) 2012
Net profit margin 8.55% 14.87%
Operating margin 12.35% 19.01%
EBITD margin - 24.59%
Return on average assets - 8.93%
Return on average equity - 17.02%
Employees 117,900 -
Carbon Disclosure Rating - 78/100

Address

One Johnson & Johnson Plaza
NEW BRUNSWICK, NJ 08933
United States - Map
+1-732-5240400 (Phone)
+1-732-2140332 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia
Discussion Group - Google Finance

Description

Johnson & Johnson is a holding company. The Company, along with its subsidiaries, is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. During the fiscal year ended January 1, 2012 (fiscal 2012), the Company�s subsidiaries operated 139 manufacturing facilities occupying approximately 21.8 million square feet of floor space. Within the United States, eight facilities are used by the Consumer segment, 10 by the Pharmaceutical segment and 34 by the Medical Devices and Diagnostics segment. In June 2012, the Company acquired Synthes, Inc.

Officers and directors

William C. Weldon Chairman of the Board
Age: 63
Bio & Compensation - Reuters
Alex Gorsky Chairman - Executive Committee, Chief Executive Officer
Age: 51
Bio & Compensation - Reuters
Dominic J. Caruso Chief Financial Officer, Vice President - Finance, Member - Executive Committee
Age: 54
Bio & Compensation - Reuters
Michael H. Ullmann Vice President, General Counsel, Member - Executive Committee
Age: 53
Bio & Compensation - Reuters
Peter M. Fasolo Vice President - Global Human Resources, Member - Executive Committee
Age: 49
Bio & Compensation - Reuters
Mary Sue Coleman Ph.D. Independent Director
Age: 68
Bio & Compensation - Reuters
James G. Cullen Presiding Independent Director
Age: 69
Bio & Compensation - Reuters
Ian E. L. Davis Independent Director
Age: 61
Bio & Compensation - Reuters
Michael M. E. Johns M.D. Independent Director
Age: 70
Bio & Compensation - Reuters
Susan L. Lindquist Ph.D. Independent Director
Age: 62
Bio & Compensation - Reuters